AGER and chronic obstructive pulmonary disease: Our study confirmed that miR-23a-5p, as the upstream regulatory negative factor of RAGE, inhibits the activation of the downstream ROS and MAPK signaling pathway, significantly improves the pathological changes and lung function induced by cigarette smoke exposure, and may become an effective drug for the treatment of COPD targeting RAGE.